Technology Offers Site map description
A
UNIVERSIDAD DE BURGOS posted this:
Age, growth and feed analysis from teeth images, applicable in palaeontology and the forensic industryTeeth analysis using software to obtain information from palaeontological remains by semi-automatic image processing. This way the human error due to the repetitive works are minimized. Moreover, it can be used in forensic odontology.
Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityTechnology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Alcoholic Jelly Shots: High Strength & Ready to DrinkAmos Nussinovitch – High Strength Alcoholic Jelly Shots – (TTM #) – The researcher developed food grade (GRAS), gelatin free and gluten free hydrocolloidal jelly shots that may contain as high as 70% alcohol and do not necessarily need refrigeration. This is unique since jelly shots available on the market today are limited to 15% alcoholic content because of the preparation used. The demand for high-strength premixed alcoholic ready-to-drink (RTD) beverages is growing at a compound annual rate of 4.5% from 2017 to 2026 and the market was $5.2 Billion in 2017. Yissum is looking to collaborate with a commercial entity that can bring this novel jelly shot to market. Patent Position: None – Know How. Scientific Article: Unpublished. Project ID : 47-2020-10909
Laser Consult Ltd. posted this:
All-natural hydrophobic oil absorbent powders and granules for environmental & industrial purposesThe technology consists of an original industrial process by which natural materials can be turned into products with hydrophobic oil adsorbent properties. The captured oil can be extracted and recycled, and the product can be reused several times over. These products can be developed as powders or granules with varying levels of hardness, water resistance, size, and density for diverse set of applications.
Pascal Mayer posted this:
Alphanosos - Leader in botanical plant-based natural antimicrobial control, well-being and medicineAlphanosos is active in animal feed, medical foods, and pharma, and with the right venture partners, to become a leader in botanical plant-based natural antimicrobial control, well-being and medicine through its R&D based on proprietary Artificial Intelligence. Alphanosos’ first patent-pending discoveries are incorporated into commercial products and generate its first revenues.
CEO at Alphanosos
Covid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by InnogetCovid-19 Innovation Challenges by Innoget posted this:
Alphanosos rapid discovery technology against COVID 19Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large amounts and with good traceability. Such treatment is, therefore, and also thanks to the innovative elaboration process, immediately available to enter large curative clinical trials, to be followed by country-wide deployment in a matter of weeks, for curative and for preventive goals (because of safety which is guaranteed by the edible nature of the mix).
Pascal Mayer posted this:
Alphanosos rapid discovery technology against COVID 19Alphanosos’ AI guided rapid discovery technology, validated in antimicrobials and anticancer, is expected to develop within 3 weeks of experimental work with a virology partner an anti-COVID-19 treatment composed of a synergistic mix of extracts of edible plants, chosen for being available in large amounts and with good traceability. Such treatment is, therefore, and also thanks to the innovative elaboration process, immediately available to enter large curative clinical trials, to be followed by country-wide deployment in a matter of weeks, for curative and for preventive goals (because of safety which is guaranteed by the edible nature of the mix).
CEO at Alphanosos
Universidad de Alcalá-OTRIUniversidad de Alcalá-OTRIUniversidad de Alcalá-OTRI posted this:
Altimeter based on radar, inertial and atmospheric pressure systems for aerial, acrobatic and unmanned vehicles.The Intelligent Systems Research Group of the University of Alcalá presents an altimeter based on radar, inertial and atmospheric pressure systems for aerial, acrobatic and unmanned vehicles. It is a sensor capable of measuring height with respect to the ground integrating radar, barometric and inertial technologies. The group seeks to achieve licensing, collaboration or commercial agreements with technical assistance, with companies or research groups related to the aeronautical and aerospace sector.
Brunel University LondonBrunel University London
Irene UcedaConsejo Superior de Investigaciones CientíficasIrene Uceda posted this:
An electrical stable electrochemical sensor device based on Electrolyte-gated field-effect transistor (EGFET)CSIC has developed an electrolyte-gated field-effect transistor (EGFET) with enhanced electrical stability. These new EGFETs operate in aqueous environment, and are stable for more than 12 hours under continuous operation, greatly surpassing current state-of-the-art EGFETs. The increased stability makes them suitable for real life applications. Industrial partners are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
Employee at Consejo Superior de Investigaciones Científicas
Unitat de Valorització de la URVFundació URVUnitat de Valorització de la URV posted this:
An electrode device for electroencephalographyA specific electrode has been designed for the recording of aEEG in the neonatal and pediatric ICU’s. The new electrode solves the problems of conventional commercial electrodes. The main difference of the new device is a design of suitable dimensions and shape that adapts to the cephalic surface of children and improves its support. It allows a safe replacement of the electroconductive gel, and a manipulation of the child without difficulties. Most available surface electrodes are not properly sized for term and preterm infant’s application. Also, they are usually attached to a long wire that connects them to the bioelectric signal amplifier. This long wire electrode hinders the manipulation of the newborn by health care staff. In addition, the electrode wire is usually attached laterally to the electrode. In the lying position, the usual position of children in the ICU’s, this joint causes a lever force that facilitates the electrode decoupling. Superficial cup electrodes available have a hole through which the electroconductive gel is replaced in order to maintain its high conductive capacity during long-term recordings. During this process, a blunt-tipped syringe is usually used to remove the old electroconductive gel and apply the new one. At this time, it is usually necessary to apply vertical pressure to beat the conductive gel layer that may have dried on the long-term recordings. This pressure can cause an involuntary contact with the scalp surface, which should be avoided in newborns due to their fragility and proximity to the fontanelles. Disposable adhesive electrodes have the disadvantage of not allowing the replacement of the electroconductive gel and therefore they must be replaced periodically. This involves more manipulation and possible changes in the recording conditions (placement, impedance, etc.). The subdermal needle electrodes which are often used in the aEEG to achieve low impedance recordings have the disadvantage of producing pain. Pain should always be avoided to improve comfort but in the aEEG it also has the disadvantage of not allowing the accurate assessment of a parameter as important as the latency of onset of the asleep-wake cycle. In addition, the subdermal electrodes have the same drawbacks as most surface electrodes available: are connected to a long wire to the amplifier and are easily detached.
Licensing Manager at Fundació URV
Universidad de Cádiz posted this:
An improved fast and high throughput method for the sequential measurement of nitrate and nitrite in water samplesWe have developed an improved fast and sequential protocol that permits the determination of low concentrations of nitrite and nitrate in aquatic samples using small volumes. It is ideal to analyse large sets of samples with different characteristics, since it is enough a small amount of water the volume and cost of reagents and consumables are reduced.Peter Mogyorosi posted this:
An Innovative Technology to Effectively Utilize and Recycle Sewage SludgeOur partner, a Hungarian company developed a patented technology that provides a solution for transforming municipal sewage sludge into solid fuel (Solid Recovered Fuel - SRF), which also enables sewage plants to achieve significant cost savings.
CEO at Laser Consult Ltd.
Fundació URV posted this:
An open-source scalable Personal Cloud that can adapt to the necessities of organizations.StackSync is an Open Source Personal Cloud that takes care of your real needs and provides a cloud storage solution with scalability, security and privacy awareness. StackSync fits perfectly in any kind of organization (e.g., Enterprise, SME, Government, Educational) offering adaptable cloud storage: private, hybrid or public. For more information: http://youtu.be/Z76poRg92hI http://stacksync.org/UNIVERSIDAD DE BURGOS posted this:
Anaerobic treatment of biodegradable waste liquidsBioreactor formed by two connected closed tanks (anaerobic digestion tank and filtration tank) for the anaerobic treatment of complex wastewater with biogas production. A support material is used, in a non-arranged way, increasing the active biomass accumulation capacity and allowing downwards flow in the digestion tank.
- Universidad de Alcalá-OTRIUniversidad de Alcalá-OTRI
Universidad de Alcalá-OTRI posted this:
Analysis and heuristic optimization software system for wind farm design.The utilization of technologies of soft computing has been vaguely applied to the optimization of the design of wind farms, and only with a limited set of parameters. Gheode group has developed a series of algorithms that consider in a much more realistic way the designing of parks, having in addition a great versatility to incorporate improvements or made-to-measure expansions for every client in particular. TTPU posted this:
Anti-adhesive Biopolymer CoatingResearchers have developed an anti-adhesive coating based on a polymer naturally and sustainable produced by a marine bacterium. This coating prevents the bacterial adhesion and the subsequent biofilm formation that usually leads to host bacterial infections difficult to eradicate and control with the antibiotics currently in use, namely in hospital environments. This coating can be applied in a cost effective way to a broad range of materials through the application of a universal glue.
Leading BiologyLeading BiologyLeading Biology posted this:
Anti-GPCR Antibody ProductionWith rich experience in antibody discovery and membrane protein studies, experts from Leading Biology have launched a membrane protein antibody development platform. We provide a one-stop service of anti-GPCR membrane protein antibody discovery service against a variety of GPCR targets now.
Business Development Manager at Leading Biology
Centre Technology Transfer CITTRUCentre Technology Transfer CITTRUCentre Technology Transfer CITTRU posted this:
Anti-histidine and Anti-arginine Tag DNA aptamers for biotechnological applicationsThe subject of the offer are unique sequences of single-stranded DNA aptamers with high affinity to any molecule (peptide, protein or DNA derivative) containing His-Tag and Arg-Tag and their application in biotechnology in analysis of His-Tagged and Arg-Tagged molecules.- Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew University
Technology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
ANTI-INFECTIOUS COATING FOR IMPLANTSSelf-assembly of fluorine-capped moieties for prevention of biofilms Keywords: self-assembly, dental, dentistry, biolfilm, disruption Project ID : 9-2015-3142
- Yissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew UniversityYissum - Research Development Company of the Hebrew University
Technology Transfer Office
View ProfileYissum - Research Development Company of the Hebrew University posted this:
Anti-Oxidants Rich, Non-GMO TomatoesJoseph Hirschberg & Daniel Zamir - Anti-Oxidants Rich, Non-GMO Tomatoes (TTM #6744) - Tomato fruits naturally accumulate the red carotenoid pigment lycopene, our Xantomato is a novel tomato variety that accumulates high levels of the natural phytochemical zeaxanthin – instead of lycopene. The reserachers used classical genetic breeding methods to take advantage of mutations that alter carotenoid production to achieve zeaxanthin levels that are as high as 35 ?g/g FW. The zeaxanthin tomatoes will not be considered “genetically modified” (GMO), thus the fruits and extracts should face no marketing limitations. Patent Position: Provisional Filed. Scientific Article: https://www.ncbi.nlm.nih.gov/pubmed/32320515 Yissum Online: http://www.yissum.co.il/technologies/project/6744 Project ID : 8-2019-6744
FrieslandCampina posted this:
Anti-telescoping device for spiral wound membranesThe anti-telescoping device causes a spiral wound membrane filter to operate at a more constant and at a lower trans membrane pressure difference than such filter without such device. It is especially useful in microfiltration and ultrafiltration devices for liquids such as fruit juices, milk, beer, waste water, fermentation broths, etc.
Ivan Rodriguez RoselloUniversidad de AlicanteIvan Rodriguez Rosello posted this:
Antibacterial alternative to antibiotics, with high specificity against Escherichia coliThe "Molecular Microbiology" research group at the University of Alicante has modified several phage proteins (Poll-N and UK-C) that have high specificity against Escherichia coli (E. coli), but not against other Gram-negative (G-) bacteria. For these reasons, their use as a specific antimicrobial against E. coli is potentially interesting, especially in the case of contaminated food, cosmetics or water. It would also be useful in the treatment of diseases (infections) caused by E. coli. The presence of a histidine tail attached to the phage proteins not only facilitates their purification but also improves lysis efficiency without the need of cell permeabilization treatments. Companies interested in the commercial exploitation of the technology through license agreements and/or technical cooperation are sought.
Licensing Manager at Universidad de Alicante
Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas posted this:
Antibiotics to treat diseases caused by HelicobacterCSIC, the University of Zaragoza, Institute Pasteur, IISA and ARAID have developed chemical derivatives that act selectively against the bacterium Helicobacter pylori, managing to reduce the bacterial load and even eradicate gastric infections caused by it. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing
CNIC (TTO)Spanish National Center for Cardiovascular Research (CNIC)CNIC (TTO)Technology Transfer Office at Spanish National Center for Cardiovascular Research (CNIC)
View ProfileCNIC (TTO) posted this:
Antibodies for the diagnosis and/or treatment of atherosclerosisNovel atherosclerosis biomarkers are in need to improve the strategies for diagnosis and prognosis of cardiovascular disease. CNIC and DKFZ researchers have discovered 18 novel antibodies that show reactivity against the atherosclerotic plaque, which can thus be potentially used for the diagnosis of this disease. Moreover, the use of one such antibody, A12, delays the progression of atherosclerosis and reduces the level of free circulating cholesterol and LDL.
Technology Transfer Office at Spanish National Center for Cardiovascular Research (CNIC)
- Consejo Superior de Investigaciones CientíficasConsejo Superior de Investigaciones Científicas
Consejo Superior de Investigaciones Científicas posted this:
Antibodies to measure residual levels of mycotoxin ochratoxin A in foodCSIC and the University of Valencia have developed antibodies capable of determining ochratoxin A in food and ensure compliance with legislation on food products regarding the presence of this mycotoxin. Antibodies have been generated using novel functionalized derivatives of ochratoxin A. These immunoreagents have shown their efficacy in both direct and indirect competitive ELISA to detect concentrations close to parts per trillion. We are looking for companies interested in patent licensing for the development of fast, sensitive and portable kits for the analysis of ochratoxin A in foods and beverages based on these antibodies. The license of the patent is offered Effective, fast and accurate detection Ochratoxin A has a higher incidence in cereals, wine, juices and coffee One of the most harmful and frequent mycotoxins in food is ochratoxin A. Its presence is a real problem for human health due to its toxicity, and it causes significant economic losses to various productive sectors. The main fungi producing ochratoxin A belongs to the genera Penicillium and Aspergillus, and the products with the highest incidence are cereals, wine, juices and coffee. The small concentrations at which this potent toxin is usually found commonly require the use of sophisticated chromatographic methods. An alternative is the generation of antibodies against ochratoxin A with superior performance to the existing ones that allow this toxin being recognized with high affinity and specificity. These immunoreagents can be easily implemented in various analytical platforms, from the simplest, such as competitive ELISAs and immunochromatographic strips, to more complex, like chips or biosensors of different types, which allows us to simultaneously analyze a large number of samples in low-resource settings such as warehouses, cellars and even farmlands. Main applications and advantages Ochratoxin A derivatives functionalized at new positions have been synthesized that faithfully preserve the structure and characteristics of this potent mycotoxin. These new compounds have proven to be extremely efficient as haptens to generate antibodies capable of recognizing ochratoxin A with an affinity and selectivity not previously described. Immunoassays developed using these immunoreagents have been shown to be very sensitive, allowing analysis of ochratoxin A at levels close to 10 parts per trillion. These new methods are faster than instrumental procedures, especially when analyzing complex samples such as wine and coffee. The generated immunoreagents are easily adaptable to portable methods, such as ELISA kits or immunochromatographic strips. Patent status Prioriy patent application filed suitable for international extension For more information contact with: Mª Jesus Añón Marín Instituto de Agroquímica y Tecnología de Alimentos Consejo Superior de Investigaciones Científicas (CSIC) Tel.: +34 963900022 E-mail: mjanon@iata.csic.es
- Universidad de Alcalá-OTRIUniversidad de Alcalá-OTRI
Universidad de Alcalá-OTRI posted this:
Anticancer activity of Ru (II) Arene complexes with oxime ligands.Spanish research group from the department of Inorganic Chemistry the University of Alcala, together with a Moroccan research group from the University of Abdelmalek Essaadi, have developed a process to synthesize metal complexes with anticancer properties, which can be used for cancer treatment and prevention. The group is looking for companies working in the pharmaceutical and biomedical sector to achieve license, collaborative or commercial agreements with technical assistance.
- Universidad de Alcalá-OTRIUniversidad de Alcalá-OTRI
Universidad de Alcalá-OTRI posted this:
Antimicrobial electrospun fiber membrane with retention and controlled release capacity of active substancesResearchers from the Department of Analytical Chemistry, Physical Chemistry and Chemical Engineering of the University of Alcalá in collaboration with researchers from the Department of Chemistry and Physics of the University of Almería, presents a procedure for the manufacture of active membranes based on submicron fibers combining an antimicrobial action with the ability to retain apolar contaminants in aqueous solution. The membranes are produced by an electrospinning process in aqueous solution from mixtures of water soluble polyacids and polyols, which are subsequently stabilized by a thermal curing process and post-functionalized by the incorporation of amino-terminated dendrimers by a grafting process using a coupling agent. The material can be applied to the treatment of drinking water, to the regeneration of waste water, to the treatment of process waters and also to the controlled release of active substances, such as drugs, food preservatives, etc. The group seeks companies from the pharmaceutical, food, material technology and environmental sectors to sign technical cooperation agreements, commercial agreement with technical assistance and patent licensing agreements.
Germans Trias i Pujol Health Sciences Research InstituteGermans Trias i Pujol Health Sciences Research InstituteGermans Trias i Pujol Health Sciences Research Institute posted this:
Apotransferrin to treat strokeOur group has demonstrated that intravenous administration of apotransferrin strongly reduces the brain damage (up to 75%) in 3 different rat models including both transient and permanent ischemic stroke and improves the neurological impairment (neuroscore 60%) induced by stroke. Thus, this new approach may benefit not only stroke patients who can be treated with current treatment to induce recanalization (transient stroke) but also the 80% of patients who could not benefit from current therapies directed to induce recanalization of the artery (permanent strokes). Results in the preclinical area and some results obtained in serum of stroke patients lead us to think that apotransferrin is a good neuroprotector in the early stages of the ischemic event.
